Looks like there is some tacit understanding
and long term view between MYX
and Mithra.
Only time will tell.
- Forums
- ASX - By Stock
- MYX
- Ann: NEXTSTELLIS FDA exclusivity & phase III data published
MYX
mayne pharma group limited
Add to My Watchlist
2.19%
!
$5.13

Ann: NEXTSTELLIS FDA exclusivity & phase III data published, page-18
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.13 |
Change
0.110(2.19%) |
Mkt cap ! $415.9M |
Open | High | Low | Value | Volume |
$5.00 | $5.14 | $4.94 | $642.2K | 127.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 1424 | $5.11 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.13 | 4632 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 150 | 5.120 |
12 | 1875 | 5.110 |
6 | 3964 | 5.100 |
2 | 849 | 5.090 |
3 | 969 | 5.080 |
Price($) | Vol. | No. |
---|---|---|
5.130 | 4395 | 10 |
5.140 | 4498 | 6 |
5.150 | 10676 | 3 |
5.160 | 6703 | 5 |
5.170 | 721 | 2 |
Last trade - 15.47pm 26/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online